J. Raffalli

发表

International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia

E. Anaissie, J. Vazquez, D. Kontoyiannis, 2005, European Journal of Clinical Microbiology and Infectious Diseases.

Tuberculosis at the end of the twentieth century

K. Sepkowitz, J. Raffalli, 1994, European Journal of Clinical Microbiology and Infectious Diseases.

Serology of Culture-Confirmed Cases of Human Granulocytic Ehrlichiosis

D. McKenna, G. Wormser, J. Dumler, 2000, Journal of Clinical Microbiology.

A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile Neutropenia

E. Anaissie, J. Wingard, A. Arrieta, 2000 .

A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group.

E. Anaissie, J. Wingard, A. Arrieta, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evaluation of dedicated stethoscopes as a potential source of nosocomial pathogens.

G. Wormser, E. Bottone, M. Montecalvo, 2002, American journal of infection control.

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.

E. Anaissie, J. Perfect, J. Wingard, 2002, The New England journal of medicine.

Tuberculosis in the AIDS era

K. Sepkowitz, L. Riley, D. Armstrong, 1995, Clinical microbiology reviews.

Failure of a lipid amphotericin B preparation to eradicate candiduria: preliminary findings based on three cases.

G. Wormser, M. Aguero-Rosenfeld, S. Lacson, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Analysis of Sequences and Loci of p44 Homologs Expressed by Anaplasma phagocytophila in Acutely Infected Patients

G. Wormser, Y. Rikihisa, N. Zhi, 2002, Journal of Clinical Microbiology.

Persistence of babesiosis for >2 years in a patient on rituximab for rheumatoid arthritis.

G. Wormser, J. Raffalli, 2016, Diagnostic microbiology and infectious disease.

International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia

D. Kontoyiannis, J. Rex, L. Ostrosky-Zeichner, 2005, European Journal of Clinical Microbiology and Infectious Diseases.

Natural History of Colonization With Vancomycin-Resistant Enterococci, Methicillin-Resistant Staphylococcus Aureus, And Resistant Gram-Negative Bacilli Among Long-Term–Care Facility Residents

G. Wormser, G. Maguire, P. Visintainer, 2003, Infection Control & Hospital Epidemiology.

Community-based outbreaks of tuberculosis.

K. Sepkowitz, D. Armstrong, J Raffalli, 1996, Archives of internal medicine.

“Vira something”: a taste of the wrong medicine

J. Nowakowski, G. Wormser, J. Raffalli, 1997, The Lancet.

Serial measurements of hematologic counts during the active phase of human granulocytic ehrlichiosis.

J. Bakken, G. Wormser, J. Dumler, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Saddleback fever due to human granulocytic ehrlichiosis

R. Nadelman, G. Wormser, H. Horowitz, 1998, The Lancet.